Bio-Rad Laboratories, Inc. (BIO)
369.14
+13.57
(+3.82%)
USD |
NYSE |
Oct 02, 16:00
368.97
-0.17
(-0.05%)
After-Hours: 20:00
Bio-Rad Laboratories Enterprise Value : 9.620B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 9.620B |
| October 01, 2026 | 9.258B |
| September 30, 2026 | 9.850B |
| September 29, 2026 | 9.899B |
| September 28, 2026 | 9.849B |
| September 25, 2026 | 9.937B |
| September 24, 2026 | 10.11B |
| September 23, 2026 | 9.881B |
| September 22, 2026 | 9.899B |
| September 21, 2026 | 9.839B |
| September 18, 2026 | 9.815B |
| September 17, 2026 | 9.975B |
| September 16, 2026 | 9.885B |
| September 15, 2026 | 9.857B |
| September 14, 2026 | 9.605B |
| September 11, 2026 | 9.625B |
| September 10, 2026 | 9.610B |
| September 09, 2026 | 9.830B |
| September 08, 2026 | 9.914B |
| September 04, 2026 | 10.07B |
| September 03, 2026 | 10.12B |
| September 02, 2026 | 10.14B |
| September 01, 2026 | 9.936B |
| August 31, 2026 | 10.07B |
| August 28, 2026 | 10.12B |
| Date | Value |
|---|---|
| August 27, 2026 | 10.18B |
| August 26, 2026 | 10.14B |
| August 25, 2026 | 10.19B |
| August 24, 2026 | 9.958B |
| August 21, 2026 | 9.912B |
| August 20, 2026 | 9.816B |
| August 19, 2026 | 9.490B |
| August 18, 2026 | 9.181B |
| August 17, 2026 | 9.248B |
| August 14, 2026 | 9.276B |
| August 13, 2026 | 9.408B |
| August 12, 2026 | 9.432B |
| August 11, 2026 | 9.276B |
| August 10, 2026 | 9.230B |
| August 07, 2026 | 9.175B |
| August 06, 2026 | 8.906B |
| August 05, 2026 | 9.051B |
| August 04, 2026 | 8.651B |
| August 03, 2026 | 8.700B |
| July 31, 2026 | 8.453B |
| July 30, 2026 | 8.486B |
| July 29, 2026 | 8.500B |
| July 28, 2026 | 8.601B |
| July 27, 2026 | 8.210B |
| July 24, 2026 | 8.158B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Thermo Fisher Scientific, Inc. | 280.71B |
| Agilent Technologies, Inc. | 49.50B |
| Danaher Corp. | 173.98B |
| Illumina, Inc. | 42.59B |
| Revvity, Inc. | 19.23B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 371.40M |
| Revenue (Quarterly) | 651.00M |
| Total Expenses (Quarterly) | 279.60M |
| EPS Diluted (Quarterly) | 13.85 |
| Gross Profit Margin (Quarterly) | 53.12% |
| Profit Margin (Quarterly) | 57.05% |
| Earnings Yield | 2.24% |
| Operating Earnings Yield | 2.36% |
| Normalized Earnings Yield | 1.738 |